Cargando…

A clinical study on the expression of PTEN in renal cell carcinoma in children

The expression pattern of tumor suppressor gene phosphatase and tensin homolog deleted on chromosome ten (PTEN) and phosphatase and tensin homolog deleted on chromosome ten/phosphatidylinositol3-kinase/protein kinase B (PTEN/PI3K/AKT) cell signaling pathway in renal cell carcinoma (RCC) were investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Hong, Tan, Yuxia, Chen, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313102/ https://www.ncbi.nlm.nih.gov/pubmed/30655739 http://dx.doi.org/10.3892/ol.2018.9571

Ejemplares similares

Relevance and Therapeutic Possibility of PTEN-Long in Renal Cell Carcinoma
por: Wang, Hui, et al.
Publicado: (2015)

In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself
por: Breuksch, Ines, et al.
Publicado: (2018)

Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis
por: Tang, Lu, et al.
Publicado: (2017)

Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome
por: Kim, Raymond H., et al.
Publicado: (2020)

MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma
por: Li, Jun, et al.
Publicado: (2020)

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxiao, et al.
Publicado: (2018)

The Infiltration of Neutrophil Granulocytes Due to Loss of PTEN Was Associated with Poor Response to Immunotherapy in Renal Cell Carcinoma
por: Wu, Fei, et al.
Publicado: (2022)

Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
por: Fan, Caibin, et al.
Publicado: (2019)

Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression
por: Lipkin, Jacob S, et al.
Publicado: (2015)

miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma
por: Park, Sang Eun, et al.
Publicado: (2022)

miR-18a Inhibitor Suppresses Leukemia Cell Proliferation by Upregulation of PTEN Expression
por: Zhang, Liping, et al.
Publicado: (2020)

p53 and PTEN expression evaluation with molecular evident recent criteria in laryngeal carcinoma
por: Tan, Ayca, et al.
Publicado: (2023)

Correlation between PTEN gene polymorphism and oral squamous cell carcinoma
por: Liu, Min, et al.
Publicado: (2019)

Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma
por: Fang, Yakun, et al.
Publicado: (2022)

miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK–PTEN axis
por: Jing, Zhi-Fei, et al.
Publicado: (2019)

Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression
por: Zhang, Han, et al.
Publicado: (2019)

miR-29 promotes the proliferation of cultured rat neural stem/progenitor cells via the PTEN/AKT signaling pathway
por: Gao, Yunan, et al.
Publicado: (2019)

MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells
por: Yu, Tingting, et al.
Publicado: (2015)

The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737
por: Tang, Lei, et al.
Publicado: (2022)

CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma
por: Zhou, Yuxia, et al.
Publicado: (2022)

Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma
por: Burgucu, Durmus, et al.
Publicado: (2012)

SPOP–PTEN–SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway
por: Han, Bo’ang, et al.
Publicado: (2021)

Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma
por: Markers, Disease
Publicado: (2023)

Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx
por: Sullu, Yurdanur, et al.
Publicado: (2010)

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas
por: Akiyama-Abe, A, et al.
Publicado: (2013)

Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma
por: ZHU, XUEHUA, et al.
Publicado: (2013)

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma
por: Lu, Yang, et al.
Publicado: (2020)

Expression and clinical significance of Apollon in renal carcinoma
por: Guo, Hongbo, et al.
Publicado: (2016)

Somatic mutation of PTEN in bladder carcinoma
por: Aveyard, J S, et al.
Publicado: (1999)

PTEN and NEDD4 in Human Breast Carcinoma
por: Chen, Yilun, et al.
Publicado: (2015)

Relationship between PTEN, DNA Mismatch Repair, and Tumor Histotype in Endometrial Carcinoma: Retained Positive Expression of PTEN Preferentially Identifies Sporadic Non-Endometrioid Carcinomas
por: Djordjevic, Bojana, et al.
Publicado: (2013)

Expression and clinical correlation of Survivin and PTEN in gastric cancer patients
por: Yusufu, Aikeremu, et al.
Publicado: (2020)

The clinical significance of PYCR1 expression in renal cell carcinoma
por: Weijin, Fu, et al.
Publicado: (2019)

Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma
por: Lu, Jianjun, et al.
Publicado: (2015)

The drug-resistance to gefitinib in PTEN low expression cancer cells is reversed by irradiation in vitro
por: Zhuang, Hong-Qing, et al.
Publicado: (2009)

The expression change of OTUD3-PTEN signaling axis in glioma cells
por: Liu, Yi-Zhen, et al.
Publicado: (2020)

TP53 and PTEN as driver mutations in Zenker's carcinoma—a clinical presentation
por: Noel, Zsanett, et al.
Publicado: (2020)

Expression of p53 and PTEN in human primary endometrial carcinomas: Clinicopathological and immunohistochemical analysis and study of their concomitant expression
por: Stavropoulos, Aggelis, et al.
Publicado: (2019)

Depletion of DNMT3A Suppressed Cell Proliferation and Restored PTEN in Hepatocellular Carcinoma Cell
por: Zhao, Zhujiang, et al.
Publicado: (2010)

Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma
por: Duman, Berna B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8tma6sueba6vju925pokhvg7l8